Delota Corp. Announces Intention to Complete Debt Settlements

2 months ago

Vaughan, Ontario--(Newsfile Corp. - January 26, 2024) - Delota Corp. (CSE: LOTA) ("Delota" or the "Company") is pleased to announce…

Advancing Imaging Without Barriers! at ECR 2024, AGFA HealthCare Shows How Enterprise Imaging Enables ‘Next-Generation Radiology’

2 months ago

At ECR in Vienna, AGFA HealthCare will demonstrate how it delivers on promises of ‘next-generation radiology' with innovations to enable…

Unexpected Inspiration for More Sustainable Drug Development at Merck

2 months ago

NORTHAMPTON, MA / ACCESSWIRE / January 26, 2024 / Inspiration for a greener world can come from unexpected places. For…

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

2 months ago

NEW YORK--(BUSINESS WIRE)--Deliberate AI, a digital health technology company that delivers precision measurement of mental health through AI, today announced…

Optimind Pharma – Debenture Conversion

2 months ago

TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the "Optimind" or the "Company") advises that…

Planet 13 to Restate Certain Previously Issued Financial Statements

2 months ago

LAS VEGAS, NV / ACCESSWIRE / January 26, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),…

Nutriband CEO Publishes Letter to Shareholders

2 months ago

ORLANDO, FL / ACCESSWIRE / January 26, 2024 / Nutriband Inc. ("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has…

SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market

2 months ago

DENVER, Jan. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (the “Company”), a medical technology company developing…

GRI Bio Announces Reverse Stock Split

2 months ago

GRI’s common stock is expected to begin trading on a post-split adjusted basis on January 30, 2024 LA JOLLA, CA,…

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

2 months ago

SAN DIEGO and TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (Nasdaq: APTO, TSX:…